Bluebird Bio Is A Biotechnology Company Based In Somervillemassachusettsspecializing In Genetherapies For Severegenetic Disorders And Cancersfounded In 1992 As Genetix Pharmaceuticalsthecompany Rebranded In 2010 And Has Sincegrown To Over 800 Employees Worldwidebluebird Bio Is Committed To Developing Onetimegenetherapies That Providelong Term Solutions For Patients With Limited Treatment Options Thecompanyaes Key Offerings Includelentiglobina Ca Therapy For Beta Thalassemia And Sicklecell Diseaseand Car T Cell Therapies For Various Cancersincluding Multiplemyelomabluebird Bio Employs Lentiviral Vector Based Genedelivery To Insert Functional Genes Into Patientshematopoietic Stem Cellsaiming For Durabletherapeutic Effectstheir Investigational Therapies Also Target Conditions Likecerebral Adrenoleukodystrophycald Bluebird Bio Collaborates With Academic Institutionshealthcareprovidersand Regulatory Bodies To Enhancepatient Access To Its Innovativetherapieswhich Aredesigned As Singledosetreatments To Reducethetreatment Burdenthecompany Continues To Focus On Advancing Its Pipelineand Ensuring Global Accessibility To Its Genetherapies
